首页> Biomedical chromatography : BMC> Anti-LSSDS pharmacological components identification of YuHuangLian based on the combination of spectrum-effect analysis and network pharmacology as well as molecular docking.

Anti-LSSDS pharmacological components identification of YuHuangLian based on the combination of spectrum-effect analysis and network pharmacology as well as molecular docking.

导出 LinkOut

翻译打印收藏纠错

第一作者： Beilei,Xu

第一单位： School of Pharmacy, Harbin University of Commerce, Harbin, China.;Engineering Research Center of Natural Anti-cancer Drugs, Ministry of Education, Harbin, China.;Heilongjiang Key Laboratory of Preventive and Therapeutic Drug Research of Senile Diseases, Harbin, China.;Engineering Research Center of Chinese Medicine Production and New Drug Development, Beijing University of TCM, Beijing, China.

作者： Beilei,Xu ^[1] ; Shengnan,Chen ^[2] ; Jingjing,Liu ^[3] ; Di,Wu ^[2] ; Wenbin,Sun ^[2] ; Shusen,Liu ^[2] ; Yang,Hu ^[4] ; Hao,Wang ^[4] ; Jinhong,Wang ^[4] ; Bo,Yang ^[4] ; Wenlan,Li ^[4] ; Shuangcheng,Ma ^[3]

作者单位： School of Pharmacy, Harbin University of Commerce, Harbin, China.;Engineering Research Center of Natural Anti-cancer Drugs, Ministry of Education, Harbin, China.;Heilongjiang Key Laboratory of Preventive and Therapeutic Drug Research of Senile Diseases, Harbin, China.;Engineering Research Center of Chinese Medicine Production and New Drug Development, Beijing University of TCM, Beijing, China. ^[1] School of Pharmacy, Harbin University of Commerce, Harbin, China. ^[2] National Institutes for Food and Drug Control, Beijing, China. ^[3] School of Pharmacy, Harbin University of Commerce, Harbin, China.;Engineering Research Center of Natural Anti-cancer Drugs, Ministry of Education, Harbin, China.;Heilongjiang Key Laboratory of Preventive and Therapeutic Drug Research of Senile Diseases, Harbin, China. ^[4]

关键词 Yu HuangLian (YHL)liver stagnation and spleen deficiency syndrome (LSSDS)pharmacological components spectrum–effect relationship